A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer
Clinical trial NCT05354700 · UNKNOWN
Trial details
- NCT number
- NCT05354700
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2024-03-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.